 Cumberland Pharmaceuticals Inc. NASDAQ: CPIX, a U.S. specialty pharmaceutical company, today announced a national initiative to support the treatment of patients with hospital-acquired and ventilator-associated pneumonia associated with the outbreak of the COVID-19 coronavirus. 